Friday, November 16, 2007

Multiple Sclerosis Resource Centre MS and Genetics Research

Multiple Sclerosis Resource Centre MS and Genetics Research
The home site of the Multiple Sclerosis Resource Centre, Multiple Sclerosis, ... The molecule PI(3,5)P2 is a lipid found in all cells at very low levels. ...

Apitope says multiple sclerosis vaccine safe
PharmaBiz Thu, 15 Nov 2007 2:57 AM PST
Apitope Technology (Bristol) Ltd., the developer of peptide-based therapies, has announced the completion of dosing for all six Multiple Sclerosis (MS) patients in a phase I/IIa trial of ATX-MS-1467.
New MS drug "a dream"
TVNZ Thu, 15 Nov 2007 11:44 AM PST
A Christchurch neurologist is describing a new drug being trialled on multiple sclerosis sufferers as a dreamą„¤
Girls on either side of Atlantic united by MS
ChronicleLive - Newcastle upon Tyne,England,UK
And at just 14, the pupil at Gateshead's Thomas Hepburn School is the only person under 18 to try out the MS wonder drug Campath. In August, specialists in ...
See all stories on this topic

New Report Analyzes Key Controversies in Multiple Sclerosis ...
Intriguing neuroprotection / neuroregeneration strategies, including. LINGO, anti-myelin-associated-glycoprotein MAb and remyelination MAb. ...

USATODAY.com - Montel Williams fights MS with fitness
Montel Williams isn't taking his multiple sclerosis (MS) lying down. The 45 year-old talk show host battles the disease's potentially debilitating effects ...

Treatment Could Reduce MS Symptoms
abc7.com - Los Angeles,CA,USA
"It's like having a sledgehammer to kill a fly," said neurology specialist Arthur Vandenbark, Ph.D. Doctor Vandenbark and his team designed RTL1000 to zero ...
See all stories on this topic

Biogen Idec's Earnings and Revenue Fall Short of Estimates
Schaeffers Research - Cincinnati,OH,USA
BIIB's newest MS drug, Tysabri, saw sales of $93 million, which was $8 million better than a year ago. Tysabri was taken off the market for a period of ...
See all stories on this topic

UPS, AT&T, Apple Post Gains
Wall Street Journal - USA
... income fell 24% on a charge related to its consolidation of Cardiokine, though it saw strong performance of multiple sclerosis drugs Avonex and Tysabri. ...
See all stories on this topic

Citi: Copaxone growth continues
Globes - Rishon Le-Zion,Israel
Teva is developing an oral multiple sclerosis therapy laquinimod, which is in Phase III clinical trials for which the company hopes to recruit 1000 patients ...
See all stories on this topic

Medistem Announces Discovery of Novel Stem Cell Population in ...
CNNMoney.com - USA
The indications currently being assessed include diabetes, liver cirrhosis, lung fibrosis, organ rejection, and multiple sclerosis. Should the data gathered ...
See all stories on this topic

Focusing On The Cellular Machinery That Enables Neurons To Fire
If you ever had a set of Micronauts -- toy robots with removable body parts -- you probably had fun swapping their heads, imagining how it would affect their behavior. Scientists supported by the National Institutes of Health have been performing similar experiments on ion channels -- pores in our nerve cells -- to sort out the channels' key functional parts.
15 Nov 2007

Latinos And African Americans Live Longer With Alzheimer's Disease
Latinos and African Americans with Alzheimer's disease live longer than white people who have the disease, according to a study published November 14, 2007, in the online edition of NeurologyĀ®, the medical journal of the American Academy of Neurology.
15 Nov 2007

0 Comments:

Post a Comment

Links to this post:

Create a Link

<< Home